Decline of Mean Initial Prednisone Dosage From 10.3 to 3.6 mg/day to Treat Rheumatoid Arthritis Between 1980 and 2004 in One Clinical Setting, With Long-Term Effectiveness of Dosages Less Than 5 mg/day-Reference-Cited by-同舟云学术

Decline of Mean Initial Prednisone Dosage From 10.3 to 3.6 mg/day to Treat Rheumatoid Arthritis Between 1980 and 2004 in One Clinical Setting, With Long-Term Effectiveness of Dosages Less Than 5 mg/day

Published:2013-04-23 Issue:5 Volume:65 Page:729-736
ISSN:2151-464X
Container-title:Arthritis Care & Research
language:en
Short-container-title:Arthritis Care Res

Author:

Pincus Theodore,Sokka Tuulikki,Castrejón Isabel,Cutolo Maurizio

Funder

Arthritis Foundation

Jack C. Massey Foundation

Publisher

Wiley

Subject

Rheumatology

Reference49 articles.

1. The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of the pituitary adrenocorticotropic hormone on rheumatoid arthritis;Hench;Proc Staff Meet Mayo Clin,1949

2. A comparison of prednisolone with aspirin or other analgesics in the treatment of rheumatoid arthritis;Joint Committee of the Medical Research Council and Nuffield Foundation;Ann Rheum Dis,1959

3. Major undesirable side-effects resulting from prednisolone and prednisone;Bollet;JAMA,1955

4. Severe functional declines, work disability, and increased mortality in seventy-five rheumatoid arthritis patients studied over nine years;Pincus;Arthritis Rheum,1984

5. Prediction of long-term mortality in patients with rheumatoid arthritis according to simple questionnaire and joint count measures;Pincus;Ann Intern Med,1994

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and risk factors of major cardiovascular events in rheumatoid arthritis and psoriatic arthritis: A population-based cohort study;Seminars in Arthritis and Rheumatism;2024-04

2. Dosis y tiempo de empleo de glucocorticoides en artritis reumatoide;Reumatología Clínica;2023-12

3. Dosage and time of use of glucocorticoids in rheumatoid arthritis;Reumatología Clínica (English Edition);2023-12

4. Glucocorticoïdes et polyarthrite rhumatoïde : trouver l’équilibre bénéfice–préjudice en exploitant la fenêtre d’opportunité thérapeutique;Revue du Rhumatisme;2023-10

5. Glucocorticoids in rheumatoid arthritis: Balancing benefits and harm by leveraging the therapeutic window of opportunity;Joint Bone Spine;2023-05